Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06184152 · ClinicalTrials.gov registry record · NA
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
A NA study of Hepatocellular Carcinoma and HCC, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 2
- Study locations
NCT06184152 is a NA study of Hepatocellular Carcinoma and HCC that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 600 participants, above the 253-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (137% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06184152, a NA study of Hepatocellular Carcinoma and HCC, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will be conducted at the following locations: 1. UT Southwestern Medical Center 2. Parkland Health and Hospital System 3. University of Michigan Investigators will prospectively compare the performance of dynamic contrast enhanced abbreviated MRI (AMRI) and contrast-enhanced ultrasound for early-stage HCC detection in patients with indeterminate liver nodules.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CEUS imaging
- DIAGNOSTIC_TEST aMRI imaging
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-11-28 |
| Est. Completion | 2028-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06184152
The ClinicalTrials.gov registry entry for NCT06184152 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 253-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (137% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which CEUS imaging is the first listed.
NCT06184152 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Texas.
Frequently Asked Questions
What is clinical trial NCT06184152 about?
NCT06184152 is a clinical study titled "CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules". The study will be conducted at the following locations: 1. UT Southwestern Medical Center 2. Parkland Health and Hospital System 3. University of Michigan Investigators will prospectively compare the performance of dynamic contrast enhanced abbreviated MRI (AMRI) and contrast-enhanced ultrasound f...
What is the current status of trial NCT06184152?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-11-28. Estimated completion is 2028-11-28.
What conditions does trial NCT06184152 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma, HCC.
What interventions are being tested in trial NCT06184152?
The interventions under investigation include: CEUS imaging (DIAGNOSTIC_TEST), aMRI imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06184152?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06184152 being conducted?
This trial has 2 study locations across Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
RECRUITING · NA
-
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
RECRUITING · NA
-
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
RECRUITING · NA
-
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
RECRUITING · NA
-
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.